Patients Blueprints for UK pharma-NHS joint working Joint working could hold at least part of the answer to getting the NHS back on its feet after COVID, according to the ABPI.
Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems.
Views & Analysis Sharing success to unlock the “triple win” of joint working The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or failure heavily dependent on the other.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
